Kum Yang Faces Delisting Threat After Receiving 'Opinion Denial' in Audit Report

COMPANY / Reporter Paul Lee / 2025-03-24 04:42:32

KUM YANG Headquarters. (Photo=KUM YANG)

 

 

[Alpha Biz= Kim Jisun] Kum Yang, a secondary battery company, is facing the threat of delisting after receiving an "opinion denial" in its audit report for last year.


According to a filing with the Financial Supervisory Service's electronic disclosure system last Friday, Kum Yang announced that it received an "opinion denial" from its auditor in the 2024 fiscal year's audit report.


When a company listed on the securities market receives an "opinion denial" from its auditor, it immediately triggers a delisting cause and becomes subject to substantial review.


Kum Yang's auditor, Hanul Accounting Firm, cited the reason for the opinion denial as "uncertainty regarding the company’s ability to continue as a going concern."


For the year 2023, Kum Yang recorded an operating loss of 56 billion KRW and a net loss of 186.1 billion KRW on a consolidated basis. In 2023, the company also posted an operating loss of 14.6 billion KRW and a net loss of 60.4 billion KRW.


Kum Yang has until the 11th of next month to file an objection. The Korea Exchange, which had suspended trading of Kum Yang's shares in response to a query regarding the audit report, will maintain the trading suspension according to listing regulations.


Meanwhile, Kum Yang's stock closed at 9,900 KRW, down 4.62% from the previous session.

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

Prosecutors Expand Probe into Misappropriation of Corporate Funds by Former Namyang Dairy Chairman Hong Won-sik and Family
Coupang App Downloads Plunge 11% Following Data Breach, Naver Plus Store Gains Momentum
Beanpole Removes 2026 Spring Collection Teaser Featuring Kim Seon-ho
National Health Insurance Service Files Appeal with Supreme Court in Tobacco Lawsuit
Financial Authorities Refer MBK Partners Management to Prosecutors Over 'Homeplus Scandal'
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS